AAP
TYRA icon

Arax Advisory Partners’s Tyra Biosciences TYRA Stock Holding History

Arax Advisory Partners’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3
Closed -$79 – 4335
2025
Q4 		$79 Sell
3
-82
-96% -$1.51K ﹤0.01% 3863
2025
Q3 		$1.19K Buy
+85
New +$969 ﹤0.01% 3220
2024
Q4 		– Sell
-7
Closed -$165 – 2749
2024
Q3 		$165 Hold
7
– – ﹤0.01% 2527
2024
Q2 		$112 Buy
+7
New +$120 ﹤0.01% 2484

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Arax Advisory Partners's TYRA Position: Q1 2026 in Review

Arax Advisory Partners sold out of Tyra Biosciences (TYRA) in Q1 2026, closing a stake of 3 shares — an estimated $79 sold.

Arax Advisory Partners first reported a position in TYRA in Q2 2024 and held it in 4 quarters. The position peaked at $1.19K in Q3 2025. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • Arax Advisory Partners reported no remaining Tyra Biosciences position as of Q1 2026 after selling out during the quarter.
  • Arax Advisory Partners sold 3 Tyra Biosciences shares in Q1 2026, an estimated $79.
  • Arax Advisory Partners first reported a position in Tyra Biosciences in Q2 2024 and held it in 4 quarters.
  • Arax Advisory Partners's Tyra Biosciences position peaked at $1.19K in Q3 2025.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on Arax Advisory Partners's 13F filing for Q1 2026, filed 13 May 2026.